Olema Pharmaceuticals Inc’s recently made public that its Director CLARK IAN T unloaded Company’s shares for reported $7.87 million on Dec 19 ’25. In the deal valued at $29.73 per share,264,800 shares were sold. As a result of this transaction, CLARK IAN T now holds 0 shares worth roughly $0.0.
Then, Myles David C. sold 51,000 shares, generating $1,553,544 in total proceeds. Upon selling the shares at $30.46, the CH. DISCOV. & NON-CLIN DEV OFF now owns 551,881 shares.
Before that, Zojwalla Naseem sold 100,000 shares. Olema Pharmaceuticals Inc shares valued at $2,804,000 were divested by the Chief Medical Officer at a price of $28.04 per share. As a result of the transaction, Zojwalla Naseem now holds 53,997 shares, worth roughly $1.49 million.
Guggenheim initiated its Olema Pharmaceuticals Inc [OLMA] rating to a Buy in a research note published on October 08, 2025; the price target was $20. A number of analysts have revised their coverage, including Citigroup’s analysts, who remained covering the stock and in mid August has reiterated a ‘”a Buy”‘ rating for it. Goldman began covering OLMA with “Buy” recommendation on April 02, 2024. Citigroup started covering the stock on January 30, 2024. It rated OLMA as “a Buy”.
Price Performance Review of OLMA
On Tuesday, Olema Pharmaceuticals Inc [NASDAQ:OLMA] saw its stock fall -1.81% to $27.67. Over the last five days, the stock has lost -19.28%. Olema Pharmaceuticals Inc shares have risen nearly 377.89% since the year began. Nevertheless, the stocks have risen 374.61% over the past one year. While a 52-week high of $36.26 was reached on 12/16/25, a 52-week low of $2.86 was recorded on 04/07/25.
Levels Of Support And Resistance For OLMA Stock
The 24-hour chart illustrates a support level at 26.94, which if violated will result in even more drops to 26.22. On the upside, there is a resistance level at 28.62. A further resistance level may holdings at 29.58.
How much short interest is there in Olema Pharmaceuticals Inc?
A steep rise in short interest was recorded in Olema Pharmaceuticals Inc stocks on 2025-11-28, growing by 2.44 million shares to a total of 10.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 8.37 million shares. There was a rise of 22.61%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 21, 2023 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $21 price target.
